Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
0(0%)
Results Posted
0%(0 trials)

Phase Distribution

Ph phase_1
1
17%
Ph not_applicable
1
17%
Ph phase_2
2
33%
Ph phase_4
1
17%
Ph early_phase_1
1
17%

Phase Distribution

2

Early Stage

2

Mid Stage

1

Late Stage

Phase Distribution6 total trials
Early Phase 1First-in-human
1(16.7%)
Phase 1Safety & dosage
1(16.7%)
Phase 2Efficacy & side effects
2(33.3%)
Phase 4Post-market surveillance
1(16.7%)
N/ANon-phased studies
1(16.7%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

50.0%

2 of 4 finished

Non-Completion Rate

50.0%

2 ended early

Currently Active

0

trials recruiting

Total Trials

6

all time

Status Distribution
Active(1)
Completed(2)
Terminated(2)
Other(1)

Detailed Status

Completed2
Withdrawn2
Not yet recruiting1
unknown1

Development Timeline

Analytics

Development Status

Total Trials
6
Active
0
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Early Phase 11 (16.7%)
Phase 11 (16.7%)
Phase 22 (33.3%)
Phase 41 (16.7%)
N/A1 (16.7%)

Trials by Status

not_yet_recruiting117%
completed233%
withdrawn233%
unknown117%

Recent Activity

Clinical Trials (6)

Drug Details

Intervention Type
DIETARY SUPPLEMENT
Total Trials
6